Tarrytown, NY, United States of America

Phil C McNeill

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Becton Dickinson and Company Limited. Active years: 2020.


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Phil C McNeill

Introduction

Phil C McNeill is an accomplished inventor based in Tarrytown, NY (US). He has made significant contributions to the field of drug delivery safety devices. His innovative approach focuses on enhancing patient safety through advanced technology.

Latest Patents

Phil C McNeill holds a patent for a safety device with a collapsible housing and trigger activation. This device is designed for drug delivery safety, featuring a trigger activation system that is activated by pressure against the skin of a patient. It automatically shields the needle after withdrawing it from the patient's skin, ensuring a safer experience for both patients and healthcare providers.

Career Highlights

Phil C McNeill is currently employed at Becton Dickinson and Company Limited, a leading global medical technology company. His work at Becton Dickinson emphasizes the importance of safety in medical devices, contributing to the development of innovative solutions that improve patient care.

Collaborations

Phil has collaborated with notable coworkers, including Edward Paul Browka and Laurie G Sanders. Their combined expertise has fostered a creative environment that encourages the development of groundbreaking medical technologies.

Conclusion

Phil C McNeill's contributions to the field of drug delivery safety devices highlight his commitment to innovation and patient safety. His work continues to influence the medical technology landscape, making a positive impact on healthcare practices.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…